Outcome of hispanic patients treated with thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-I and -III trials

Journal of the American College of Cardiology

Volumn 34, Issue 6, 1999, Pages 1729-1737

  Cohen, Mauricio G ^a,f   Granger, Christopher B ^a   Ohman, E Magnus ^a   Stebbins, Amanda L ^a   Grinfeld, Liliana R ^b   Cagide, Arturo M ^b   Elizari, Marcelo V ^c   Betriu, Amadeo ^d   Kong, David F ^a   Topol, Eric J ^e   Califf, Robert M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d UNIVERSITY OF BARCELONA   (Spain)

^e LERNER RESEARCH INSTITUTE   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; INOTROPIC AGENT; LIDOCAINE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BYPASS SURGERY; CLINICAL TRIAL; ETHNIC GROUP; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; STREPTOKINASE; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0033571510     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00433-7     Document Type: Article

References (42)

1. Day J. Population projections of the United States by age, sex, race and Hispanic origin: 1995 to 2050. Washington, DC: US Government Printing Office, US Bureau of the Census, Current Population Reports, 1996:P25-1130.
2. Center for Disease Control and Prevention. Use of race and ethnicity in public health surveillance. Summary of the CDC/ATSDR Workshop. MMWR 1993;42(No. RR-10):1-17.
3. Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by Hispanic status in the United States. JAMA 1993;270:2464-8.
4. Liao Y, Cooper RS, Cao G, Kaufman JS, Long AE, McGee DL. Mortality from coronary heart disease and cardiovascular disease among adult U.S. Hispanics: findings from the National Health Interview Survey (1986 to 1994). J Am Coll Cardiol 1997;30:1200-5.
5. Becker TM, Wiggins C, Key CR, Samet JM. Ischemic heart disease mortality in Hispanics, American Indians and non-Hispanic whites in New Mexico, 1958-1982. Circulation 1988;78:302-9.
6. Friis R, Nanjundappa G, Prendergast TJ Jr, Welsh M. Coronary heart disease mortality and risk among Hispanics and non-Hispanics in Orange County, California. Public Health Reports 1981;96:418-22.
7. Wild SH, Laws A, Fortmann SP, Varady AN, Byrne CD. Mortality from coronary heart disease and stroke for six ethnic groups in California, 1985 to 1990. Ann Epidemiol 1995;5:432-9.
8. Stern MP, Bradshaw BS, Eifler CW, Fong DS, Hazuda HP, Rosenthal M. Secular decline in death rates due to ischemic heart disease in Mexican Americans and non-Hispanic whites in Texas, 1970-1980. Circulation 1987;76:1245-50.
9. Norris SL, deBuzman M, Sobel E, Brooks S, Haywood LJ. Risk factors and mortality among black, Caucasian and Latina women with acute myocardial infarction. Am Heart J 1993;126:1312-9.
10. Goff DC Jr, Ramsey DJ, Labarthe DR, Nichaman MZ. Greater case-fatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men. The Corpus Christi Heart Project. Am J Epidemiol 1994;139:474-83.
11. Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP. Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. Circulation 1991;83:45-51.
12. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and noninsulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 1992;135:1321-30.
13. Burchfiel CM, Hamman RF, Marshall JA, Baxter J, Kahn LB, Amirani JJ. Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study. Am J Epidemiol 1990;131:57-70.
14. Baxter J, Hamman RF, Lopez TK, Marshall JA, Hoag S, Swenson CJ. Excess incidence of known noninsulin-dependent diabetes mellitus (NIDDM) in Hispanics compared with non-Hispanic whites in the San Luis Valley, Colorado. Ethnicity & Dis 1993;3:11-21.
15. Orlander PR, Goff DC, Morrissey M, et al. The relation of diabetes to the severity of acute myocardial infarction and postmyocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 1994;43:897-902.
16. Wei M, Mitchell BD, Haffner SM, Stern MP. Effects of cigarette smoking, diabetes, high cholesterol and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 1996;144:1058-65.
17. Mitchell BD, Stern MP, Haffner SM, Hazuda HP, Patterson JK. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol 1990;131:423-33.
18. Ginzberg E. Access to health care for Hispanics. JAMA 1991;265:238-41.
19. Trevino FM, Moyer ME, Valdez RB, Stroup-Benham CA. Health insurance coverage and utilization of health services by Mexican Americans, mainland Puerto Ricans and Cuban Americans. JAMA 1991;265:233-7.
20. Taylor HA, Chaitman BR, Rogers WJ, et al. Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. Circulation 1993;88:1484-94.
21. Canto J, Taylor H, Rogers W, Sanderson B, Hilbe J, Barron H. Presenting characteristics, treatment patterns and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. Am J Cardiol 1998;82:1013-8.
22. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993:673-82.
23. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO-III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997:1118-23.
24. US Bureau of the Census. Statistical Abstract of the United States: 1997 (117th edition). Washington (DC) 1997.
25. Van de Werf F, Topol E, Lee K, et al. Use of medical resources and quality of life after acute myocardial infarction in the United States and other countries: results from the GUSTO trial. JAMA 1995;273:1586-91.
26. Holmes D, Califf R, Van de Werf F, et al. Difference in countries' use of resource and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997;349:75-8.
27. Lee K, Woodlief L, Topol E, et al. Predictors of 30-day mortality in the era of reperfusion: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
28. Herrera CR, Stern MP, Goff D, Villagomez E. Mortality among Hispanics [letter; comment]. JAMA 1994;271:1237.
29. Caralis PV. Hypertension in the Hispanic-American population. Am J Med 1990;88:9S-16S.
30. Council on Scientific Affairs. Hispanic health in the United States. JAMA 1991;265:248-52.
31. Dracup K, Alonzo AA, Atkins JM, et al. The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Ann Intern Med 1997;126:645-51.
32. Clark LT, Bellam SV, Shah AH, Feldman JG. Analysis of prehospital delay among inner-city patients with symptoms of myocardial infarction: implications for therapeutic intervention. J Nat Med Assoc 1992;84:931-7.
33. Alonzo AA. The impact of the family and lay others on care-seeking during life-threatening episodes of suspected coronary artery disease. Social Sci Med 1986;22:1297-311.
34. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996;335:1198-205.
35. Carlisle DM, Leake BD, Shapiro MF. Racial and ethnic differences in the use of invasive cardiac procedures among cardiac patients in Los Angeles County, 1986 through 1988. Am J Public Health 1995;85:352-6.
36. Ramsey DJ, Goff DC, Wear ML, Labarthe DR, Nichaman MZ. Sex and ethnic differences in use of myocardial revascularization procedures in Mexican Americans and non-Hispanic whites: the Corpus Christi Heart Project. J Clin Epidemiol 1997;50:603-9.
37. Wenneker MB, Weissman JS, Epstein AM. The association of payer with utilization of cardiac procedures in Massachusetts. JAMA 1990;264:1255-60.
38. Schecter AD, Goldschmidt-Clermont PJ, McKee G, et al. Influence of gender, race and education on patient preferences and receipt of cardiac catheterizations among coronary care unit patients. Am J Cardiol 1996;78:996-1001.
39. Herholz H, Goff DC, Ramsey DJ, et al. Women and Mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-Hispanic whites: the Corpus Christi Heart Project, 1988-1990. J Clin Epidemiol 1996;49:279-87.
40. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88:1973-98.
41. Farmer IP, Meyer PS, Ramsey DJ, et al. Higher levels of social support predict greater survival following acute myocardial infarction: the Corpus Christi Heart Project. Behav Med 1996;22:59-66.
42. Goff DC, Nichaman MZ, Chan W, Ramsey DJ, Labarthe DR, Ortiz C. Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites. The Corpus Christi Heart Project, 1988-1992. Circulation 1997;95:1433-40.